Nijhawan Pardeep 4

4 · Edesa Biotech, Inc. · Filed Mar 2, 2026

AI-generated summary of this filing

Updated Mar 2, 2026

Edesa Biotech (EDSA) CEO Pardeep Nijhawan Receives RSU Award

What Happened

Pardeep Nijhawan, CEO of Edesa Biotech (EDSA), was granted 82,236 restricted share units (RSUs) on 2026-02-19. The RSUs were reported as acquired at $0.00 and vested in full upon grant. According to the filing, these RSUs were awarded in lieu of a portion of the CEO’s cash bonus earned for the calendar year ended December 31, 2025.

Key Details

Transaction date: 2026-02-19; Grant/award (Code A) of 82,236 RSUs at $0.00 per share (acquisition value $0).
Filing date: 2026-03-02 (filed 11 days after the transaction date), which is later than the typical 2-business-day Form 4 deadline.
Shares owned after the transaction: not specified in the information provided in this summary.
Footnotes of note:
- F1: RSUs vested in full upon grant under the Issuer’s 2019 Equity Incentive Compensation Plan; awarded in lieu of part of the 2025 cash bonus.
- F2 & F3: Some reported shares are held through entities and a family trust wholly or co-controlled by the reporting person; the reporting person disclaims beneficial ownership except to the extent of pecuniary interest.

Context

RSUs are equity awards that convert to shares upon vesting; because these RSUs vested immediately, the reporting person effectively received shares rather than an option that must be exercised.
Awards issued in lieu of cash bonuses are a common compensation mechanism and do not necessarily signal a buy or sell preference by the insider.
The late filing may reflect a reporting delay; while important for compliance, a late Form 4 alone is not a direct indicator of company fundamentals.

Form 4

Period: 2026-02-19

DirectorChief Executive Officer10% Owner

Transactions

Holdings

Common Shares
[F2]
(indirect: Held by Pardeep Nijhawan Medicine Professional Corporation)
341,702
Common Shares
[F3]
(indirect: By Trust)
32,609
Common Shares
[F2]
(indirect: Held by The Digestive Health Clinic Inc.)
32,013
Common Shares
[F2]
(indirect: Held by 1968160 Ontario Inc.)
53,104

Footnotes (3)

[F1]Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2025.
[F2]Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F3]Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Signature

/s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan|2026-03-02

1 file